216 related articles for article (PubMed ID: 36615517)
1. The Lipophilic Purine Nucleoside-Tdp1 Inhibitor-Enhances DNA Damage Induced by Topotecan In Vitro and Potentiates the Antitumor Effect of Topotecan In Vivo.
Chernyshova IA; Zakharenko AL; Kurochkin NN; Dyrkheeva NS; Kornienko TE; Popova NA; Nikolin VP; Ilina ES; Zharkov TD; Kupryushkin MS; Oslovsky VE; Drenichev MS; Lavrik OI
Molecules; 2022 Dec; 28(1):. PubMed ID: 36615517
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and Biological Activities of 11- and 12-Substituted Benzophenanthridinone Derivatives as DNA Topoisomerase IB and Tyrosyl-DNA Phosphodiesterase 1 Inhibitors.
Yang H; Qin C; Wu M; Wang FT; Wang W; Agama K; Pommier Y; Hu DX; An LK
ChemMedChem; 2023 May; 18(10):e202200593. PubMed ID: 36932053
[TBL] [Abstract][Full Text] [Related]
3. New Hybrid Compounds Combining Fragments of Usnic Acid and Thioether Are Inhibitors of Human Enzymes TDP1, TDP2 and PARP1.
Dyrkheeva NS; Filimonov AS; Luzina OA; Orlova KA; Chernyshova IA; Kornienko TE; Malakhova AA; Medvedev SP; Zakharenko AL; Ilina ES; Anarbaev RO; Naumenko KN; Klabenkova KV; Burakova EA; Stetsenko DA; Zakian SM; Salakhutdinov NF; Lavrik OI
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768766
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of Methoxy-, Methylenedioxy-, Hydroxy-, and Halo-Substituted Benzophenanthridinone Derivatives as DNA Topoisomerase IB (TOP1) and Tyrosyl-DNA Phosphodiesterase 1 (TDP1) Inhibitors and Their Biological Activity for Drug-Resistant Cancer.
Hu DX; Tang WL; Zhang Y; Yang H; Wang W; Agama K; Pommier Y; An LK
J Med Chem; 2021 Jun; 64(11):7617-7629. PubMed ID: 34008967
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of the Antitumor and Antimetastatic Effect of Topotecan and Normalization of Blood Counts in Mice with Lewis Carcinoma by Tdp1 Inhibitors-New Usnic Acid Derivatives.
Kornienko TE; Chepanova AA; Zakharenko AL; Filimonov AS; Luzina OA; Dyrkheeva NS; Nikolin VP; Popova NA; Salakhutdinov NF; Lavrik OI
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38279210
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of 11-aminoalkoxy substituted benzophenanthridine derivatives as tyrosyl-DNA phosphodiesterase 1 inhibitors and their anticancer activity.
Yang H; Wang FT; Wu M; Wang W; Agama K; Pommier Y; An LK
Bioorg Chem; 2022 Jun; 123():105789. PubMed ID: 35429714
[TBL] [Abstract][Full Text] [Related]
7. Natural Products and Their Derivatives as Inhibitors of the DNA Repair Enzyme Tyrosyl-DNA Phosphodiesterase 1.
Zakharenko AL; Luzina OA; Chepanova AA; Dyrkheeva NS; Salakhutdinov NF; Lavrik OI
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982848
[TBL] [Abstract][Full Text] [Related]
8. Discovery, Synthesis, and Evaluation of Oxynitidine Derivatives as Dual Inhibitors of DNA Topoisomerase IB (TOP1) and Tyrosyl-DNA Phosphodiesterase 1 (TDP1), and Potential Antitumor Agents.
Zhang XR; Wang HW; Tang WL; Zhang Y; Yang H; Hu DX; Ravji A; Marchand C; Kiselev E; Ofori-Atta K; Agama K; Pommier Y; An LK
J Med Chem; 2018 Nov; 61(22):9908-9930. PubMed ID: 30336023
[TBL] [Abstract][Full Text] [Related]
9. New 5-Hydroxycoumarin-Based Tyrosyl-DNA Phosphodiesterase I Inhibitors Sensitize Tumor Cell Line to Topotecan.
Khomenko TM; Zakharenko AL; Kornienko TE; Chepanova AA; Dyrkheeva NS; Artemova AO; Korchagina DV; Achara C; Curtis A; Reynisson J; Volcho KP; Salakhutdinov NF; Lavrik OI
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298106
[TBL] [Abstract][Full Text] [Related]
10. [Antitumor Activity of the Combination of Topotecan and Tyrosyl-DNA-Phosphodiesterase 1 Inhibitor on Model Krebs-2 Mouse Ascite Carcinoma].
Dyrkheeva NS; Zakharenko AL; Novoselova ES; Chepanova AA; Popova NA; Nikolin VP; Luzina OA; Salakhutdinov NF; Ryabchikova EI; Lavrik OI
Mol Biol (Mosk); 2021; 55(2):312-317. PubMed ID: 33871444
[TBL] [Abstract][Full Text] [Related]
11. Transcriptomic Analysis of CRISPR/Cas9-Mediated PARP1-Knockout Cells under the Influence of Topotecan and TDP1 Inhibitor.
Dyrkheeva NS; Malakhova AA; Zakharenko AL; Okorokova LS; Shtokalo DN; Pavlova SV; Medvedev SP; Zakian SM; Nushtaeva AA; Tupikin AE; Kabilov MR; Khodyreva SN; Luzina OA; Salakhutdinov NF; Lavrik OI
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982223
[TBL] [Abstract][Full Text] [Related]
12. Adamantane-Monoterpenoid Conjugates Linked via Heterocyclic Linkers Enhance the Cytotoxic Effect of Topotecan.
Munkuev AA; Dyrkheeva NS; Kornienko TE; Ilina ES; Ivankin DI; Suslov EV; Korchagina DV; Gatilov YV; Zakharenko AL; Malakhova AA; Reynisson J; Volcho KP; Salakhutdinov NF; Lavrik OI
Molecules; 2022 May; 27(11):. PubMed ID: 35684313
[TBL] [Abstract][Full Text] [Related]
13. Influence of Tyrosyl-DNA Phosphodiesterase 1 Inhibitor on the Proapoptotic and Genotoxic Effects of Anticancer Agent Topotecan.
Chepanova AA; Zakharenko AL; Dyrkheeva NS; Chernyshova IA; Zakharova OD; Ilina ES; Luzina OA; Salakhutdinov NF; Lavrik OI
Dokl Biochem Biophys; 2023 Feb; 508(1):25-30. PubMed ID: 36653585
[TBL] [Abstract][Full Text] [Related]
14. The First Berberine-Based Inhibitors of Tyrosyl-DNA Phosphodiesterase 1 (Tdp1), an Important DNA Repair Enzyme.
Gladkova ED; Nechepurenko IV; Bredikhin RA; Chepanova AA; Zakharenko AL; Luzina OA; Ilina ES; Dyrkheeva NS; Mamontova EM; Anarbaev RO; Reynisson J; Volcho KP; Salakhutdinov NF; Lavrik OI
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32998385
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of indenoisoquinolines that inhibit both tyrosyl-DNA phosphodiesterase I (Tdp1) and topoisomerase I (Top1).
Conda-Sheridan M; Reddy PV; Morrell A; Cobb BT; Marchand C; Agama K; Chergui A; Renaud A; Stephen AG; Bindu LK; Pommier Y; Cushman M
J Med Chem; 2013 Jan; 56(1):182-200. PubMed ID: 23259865
[TBL] [Abstract][Full Text] [Related]
16. Novel tyrosyl-DNA phosphodiesterase 1 inhibitors enhance the therapeutic impact of topoteсan on in vivo tumor models.
Zakharenko AL; Luzina OA; Sokolov DN; Kaledin VI; Nikolin VP; Popova NA; Patel J; Zakharova OD; Chepanova AA; Zafar A; Reynisson J; Leung E; Leung IKH; Volcho KP; Salakhutdinov NF; Lavrik OI
Eur J Med Chem; 2019 Jan; 161():581-593. PubMed ID: 30396105
[TBL] [Abstract][Full Text] [Related]
17. Secondary metabolites from Isodon ternifolius (D. Don) Kudo and their anticancer activity as DNA topoisomerase IB and Tyrosyl-DNA phosphodiesterase 1 inhibitors.
Zhang HL; Zhang Y; Yan XL; Xiao LG; Hu DX; Yu Q; An LK
Bioorg Med Chem; 2020 Jun; 28(11):115527. PubMed ID: 32345458
[TBL] [Abstract][Full Text] [Related]
18. Novel group of tyrosyl-DNA-phosphodiesterase 1 inhibitors based on disaccharide nucleosides as drug prototypes for anti-cancer therapy.
Komarova AO; Drenichev MS; Dyrkheeva NS; Kulikova IV; Oslovsky VE; Zakharova OD; Zakharenko AL; Mikhailov SN; Lavrik OI
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1415-1429. PubMed ID: 30191738
[TBL] [Abstract][Full Text] [Related]
19. Novel TDP1 Inhibitors: Disubstituted Thiazolidine-2,4-Diones Containing Monoterpene Moieties.
Ivankin DI; Kornienko TE; Mikhailova MA; Dyrkheeva NS; Zakharenko AL; Achara C; Reynisson J; Golyshev VM; Luzina OA; Volcho KP; Salakhutdinov NF; Lavrik OI
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835244
[TBL] [Abstract][Full Text] [Related]
20. Promising New Inhibitors of Tyrosyl-DNA Phosphodiesterase I (Tdp 1) Combining 4-Arylcoumarin and Monoterpenoid Moieties as Components of Complex Antitumor Therapy.
Khomenko TM; Zakharenko AL; Chepanova AA; Ilina ES; Zakharova OD; Kaledin VI; Nikolin VP; Popova NA; Korchagina DV; Reynisson J; Chand R; Ayine-Tora DM; Patel J; Leung IKH; Volcho KP; Salakhutdinov NF; Lavrik OI
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31878088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
